| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| R&D Expense | $160.3M | +57.4% |
| SG&A Expense | $48.0M | -11.4% |
| Pre-tax Income | -$211.0M | -34.5% |
| Income Tax | $9K | +110.7% |
| Net Income | -$211.0M | -34.6% |
| EPS (Basic) | -$1.71 | -19.6% |
| EPS (Diluted) | -$1.71 | -19.6% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $376.5M | -23.8% |
| Accounts Receivable | $700K | -94.3% |
| Current Assets | $404.3M | -21.2% |
| Total Assets | $405.8M | -21.3% |
| Current Liabilities | $43.3M | -2.7% |
| Total Liabilities | $43.3M | -5.2% |
| Stockholders' Equity | $362.5M | -22.8% |
| Line Item | 2023-03-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$188.2M | -77.4% |
| Capital Expenditures | $197K | -22.4% |
| Investing Cash Flow | -$197K | +22.4% |
| Financing Cash Flow | $70.9M | -64.6% |
| Free Cash Flow | -$188.4M | -77.1% |